Analgesic medication use and risk of epithelial ovarian cancer in African American women

作者: Lauren C Peres , Fabian Camacho , Sarah E Abbott , Anthony J Alberg , Elisa V Bandera

DOI: 10.1038/BJC.2016.39

关键词: DiseaseInternal medicineEpidemiology of cancerCase-control studyPopulationOvarian cancerAcetaminophenMedicineAnalgesicAspirinAnesthesia

摘要: Existing literature examining analgesic medication use and epithelial ovarian cancer (EOC) risk has been inconsistent, with the majority of studies reporting an inverse association. Race-specific effects this relationship have not adequately addressed. Utilising data from largest population-based case–control study EOC in African Americans, American Cancer Epidemiology Study, between (aspirin, non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs), acetaminophen) was estimated by multivariate logistic regression. The association frequency, duration, indication on also assessed. Aspirin use, overall, associated a 44% lower (OR=0.56; 95% CI=0.35–0.92) 26% observed for NSAID (OR=0.74; CI=0.52–1.05). strongest women taking aspirin to prevent cardiovascular disease NSAIDs arthritis. Significantly decreased risks were low-dose daily <5 years, occasional duration ⩾5 years. No acetaminophen use. Collectively, these findings support previous evidence that any is inversely risk.

参考文章(29)
P. F. Coogan, L. Rosenberg, J. R. Palmer, S. Shapiro, Brian Strom, R. S. Rao, P. D. Stolley, A. G. Zauber, A Case-Control Study of Analgesic Use and Ovarian Cancer Cancer Epidemiology, Biomarkers & Prevention. ,vol. 9, pp. 933- 937 ,(2000)
Michael Paalani, Ella Haddad, Jerry W. Lee, Serena Tonstad, Determinants of inflammatory markers in a bi-ethnic population. Ethnicity & Disease. ,vol. 21, pp. 142- 149 ,(2011)
Kathleen M. Fairfield, David J. Hunter, Charles S. Fuchs, Graham A. Colditz, Susan E. Hankinson, Aspirin, other NSAIDs, and ovarian cancer risk (United States) Cancer Causes & Control. ,vol. 13, pp. 535- 542 ,(2002) , 10.1023/A:1016380917625
Xiaojian Ni, Jingjing Ma, Yingchun Zhao, Ying Wang, Shui Wang, Meta-analysis on the association between non-steroidal anti-inflammatory drug use and ovarian cancer British Journal of Clinical Pharmacology. ,vol. 75, pp. 26- 35 ,(2013) , 10.1111/J.1365-2125.2012.04290.X
Megan A. Murphy, Britton Trabert, Hannah P. Yang, Yikyung Park, Louise A. Brinton, Patricia Hartge, Mark E. Sherman, Albert Hollenbeck, Nicolas Wentzensen, Non-steroidal anti-inflammatory drug use and ovarian cancer risk: findings from the NIH-AARP Diet and Health Study and systematic review Cancer Causes & Control. ,vol. 23, pp. 1839- 1852 ,(2012) , 10.1007/S10552-012-0063-2
Arslan Akhmedkhanov, Paolo Toniolo, Anne Zeleniuch-Jacquotte, Ikuko Kato, Karen L. Koenig, Roy E. Shore, Aspirin and epithelial ovarian cancer. Preventive Medicine. ,vol. 33, pp. 682- 687 ,(2001) , 10.1006/PMED.2001.0945
Joellen M. Schildkraut, Patricia G. Moorman, Susan Halabi, Brian Calingaert, Jeffrey R. Marks, Andrew Berchuck, Analgesic drug use and risk of ovarian cancer. Epidemiology. ,vol. 17, pp. 104- 107 ,(2006) , 10.1097/01.EDE.0000190538.55645.F8
Anna H. Wu, Celeste L. Pearce, Chiu-Chen Tseng, Claire Templeman, Malcolm C. Pike, Markers of inflammation and risk of ovarian cancer in Los Angeles County International Journal of Cancer. ,vol. 124, pp. 1409- 1415 ,(2009) , 10.1002/IJC.24091
Melissa A. Merritt, Adèle C. Green, Christina M. Nagle, Penelope M. Webb, , Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer. International Journal of Cancer. ,vol. 122, pp. 170- 176 ,(2008) , 10.1002/IJC.23017